RBC Capital维持Alnylam股票300美元目标价，看好市场准入前景
周二，RBC Capital Markets重申了对Alnylam Pharmaceuticals (NASDAQ: ALNY ...
RBC下调Edgewell Personal Care目标价至43美元，维持"跑赢大市"评级
周二，RBC Capital Markets调整了对Edgewell Personal ...